Home About us Editorial board Ahead of print Browse Articles Search Submit article Instructions Subscribe Contacts Login 
  • Users Online: 260
  • Home
  • Print this page
  • Email this page

    Article Cited by others


Anticoagulation therapy in COVID-19 patients with chronic kidney disease

Shafiee Mohammad Ali, Hosseini Sayyideh Forough, Mortazavi Mojgan, Emami Anahita, Mojtahed Zadeh Mahtab, Moradi Sanaz, Shaker Pouyan

Year : 2021| Volume: 26| Issue : 1 | Page no: 63-63

   This article has been cited by
1 Targeting ACE2 as a potential prophylactic strategy against COVID-19-induced exacerbation of chronic kidney disease
Itsuro Kazama
Inflammation Research. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Good practice statements for antithrombotic therapy in the management of COVID -19: Guidance from the SSC of the ISTH
Alex C. Spyropoulos, Jean M. Connors, James D. Douketis, Mark Goldin, Beverley J. Hunt, Taiwo R. Kotila, Renato D. Lopes, Sam Schulman
Journal of Thrombosis and Haemostasis. 2022;
[Pubmed]  [Google Scholar] [DOI]


Read this article